Results 31 to 40 of about 16,099 (284)

Cystic Fibrosis, Atopy, Asthma and ABPA [PDF]

open access: yes, 2010
The role of atopy on cystic fibrosis (CF) progression remains unclear but evidence suggests that it may influence the appearance of co-morbid conditions such as CF asthma or allergic bronchopulmonary aspergillosis (ABPA).
A. Fernandes   +95 more
core   +1 more source

Prospective evaluation of a new Aspergillus IgG EIA kit for the diagnosis of chronic and allergic pulmonary aspergillosis [PDF]

open access: yes, 2016
International ...
Bailly, S.   +12 more
core   +4 more sources

Allergic bronchopulmonary aspergillosis misdiagnosed as pneumonia

open access: yesMRIMS Journal of Health Sciences, 2021
Allergic bronchopulmonary aspergillosis (ABPA) is a fungal infection of lung predisposing in long-standing bronchial asthma and cystic fibrosis patients.
Tarun Kumar Suvvari   +4 more
doaj   +1 more source

Aspergillus felis in Patient with Chronic Granulomatous Disease

open access: yesEmerging Infectious Diseases, 2019
We report a case of Aspergillus felis infection in a patient with chronic granulomatous disease who had overlapping features of invasive pulmonary aspergillosis and allergic bronchopulmonary aspergillosis.
Olivier Paccoud   +8 more
doaj   +1 more source

Blood basophils from cystic fibrosis patients with allergic bronchopulmonary aspergillosis are primed and hyper-responsive to stimulation by aspergillus allergens [PDF]

open access: yes, 2012
IntroductionFifteen to sixty percent of cystic fibrosis patients harbor Aspergillus fumigatus (Af) in their airways (CF-AC) and some will develop allergic bronchopulmonary aspergillosis (CF-ABPA).
Davies, Zoe A.   +9 more
core   +1 more source

Use of monoclonal antibodies for allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis: literature review

open access: yesTherapeutic Advances in Respiratory Disease, 2020
Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity reaction (HR) mediated by antigens to Aspergillus fumigatus. It is estimated that 2–15% of patients with cystic fibrosis (CF) and between 1% and 5% of asthmatics develop ABPA, affecting
Isabel Eraso   +3 more
semanticscholar   +1 more source

The basophil surface marker CD203c identifies Aspergillus species sensitization in patients with cystic fibrosis. [PDF]

open access: yes, 2015
BACKGROUND: Colonization by Aspergillus fumigatus in patients with cystic fibrosis (CF) can cause A fumigatus sensitization and/or allergic bronchopulmonary aspergillosis (ABPA), which affects pulmonary function and clinical outcomes. Recent studies show
Azim, Ahmed Abdul   +14 more
core   +2 more sources

Recurrent hemoptysis in a patient with bronchial asthma

open access: yesJournal of Advanced Lung Health, 2021
Hemoptysis is not a common symptom in bronchial asthma. We aim to discuss the approach to a patient with uncontrolled asthma with recurrent hemoptysis in this case-based discussion.
Vishnu M Sharma, Baseer Ahmmad Walikar
doaj   +1 more source

Bronchiectasis:a case-based approach to investigation and management [PDF]

open access: yes, 2018
Bronchiectasis is a chronic respiratory disease characterised by a syndrome of productive cough and recurrent respiratory infections due to permanent dilatation of the bronchi.
Agarwal   +17 more
core   +3 more sources

Prevalence and Risk Factors of Allergic Bronchopulmonary Aspergillosis and Aspergillus Sensitization in Children with Poorly Controlled Asthma.

open access: yesJournal of Tropical Pediatrics, 2020
BACKGROUND Allergic bronchopulmonary aspergillosis (ABPA) may be a risk factor for poorly controlled asthma in children. The studies regarding prevalence and risk factors of ABPA in children with poorly controlled asthma are limited in number ...
J. Kumari   +5 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy